ArticleJournal of obesity & metabolic syndrome2025
Ferulic Acid Attenuates Aortic Stiffening and Cardiovascular Remodeling by Suppressing Inflammation and the Renin-Angiotensin System in Rats Fed a High-Fat/High-Carbohydrate Diet.
Article in Journal of obesity & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting hypertension through natural phenolics: The multifaceted role of cinnamic acid and its derivatives.Pflugers Archiv : European journal of physiology · 2026Review
- Pharmacology-Driven Dissection of Core Component Sets of Xuefu Zhuyu Decoction in Blood Stasis-Related Cardiovascular Diseases.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ferulic acid (FA) is an antioxidant compound present in cereals, fruits, and vegetables. Chronic consumption of a high-fat and high-carbohydrate (HFHC) diet can lead to metabolic syndrome and increase the risk of atherosclerotic cardiovascular disease. This study examined whether FA could mitigate vascular inflammation, aortic stiffness, and cardiovascular remodeling in rats fed a HFHC diet. Methods: Male Sprague-Dawley rats were divided into five groups (eight rats/group): one group was fed a standard chow diet with or without FA supplementation, while the others were fed a HFHC diet plus a 15% fructose solution for 16 weeks. Rats on the HFHC diet received FA at doses of 0, 30, or 60 mg/kg/day during the final 6 weeks of the study. Various cardiovascular parameters, plasma biochemical markers, and the expression of biomarker proteins were measured. Results: FA administration alleviated the metabolic disturbances caused by the HFHC diet. FA reduced arterial blood pressure, aortic pulse wave velocity, oxidative stress, vascular inflammation, and angiotensin-mediated myocardial fibrosis and cardiac hypertrophy, as evidenced by decreases in ventricular interstitial fibrosis and cross-sectional area. These beneficial effects were associated with reduced vascular superoxide production and lower plasma levels of angiotensin-converting enzyme and tumor necrosis factor α. FA also suppressed the expression of Ang II type 1 receptor, gp91 Conclusion: This study provides insightful findings on the beneficial effects of FA in reducing aortic stiffness and cardiovascular remodeling associated with metabolic syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.